RHÖN-KLINIKUM Stock Forecast for 2023 - 2025 - 2030

Updated on 04/18/2024

Stock Rating
16
Price Target
0.00€
Consensus
-
Upside
38.89%
Analysts
0
Stock Rating
16
Upside
38.89%
Analysts
0
Price Target
0.00€
-

RHÖN-KLINIKUM Fair Value Forecast for 2023 - 2025 - 2030

In the last two years, RHÖN-KLINIKUM's Price has decreased from 19.72€ to 0.00€ – a 100.00% drop. In the next year, analysts believe that Fair Value will reach 0.00€ – an increase of 100.00%. For the next six years, the forecast is for Fair Value to grow by 100.00%.

2025 Fair Value Forecast
0.00€
2026 Fair Value Forecast
0.00€
2027 Fair Value Forecast
0.00€
2028 Fair Value Forecast
0.00€
2029 Fair Value Forecast
0.00€
2030 Fair Value Forecast
0.00€

RHÖN-KLINIKUM Revenue Forecast for 2023 - 2025 - 2030

RHÖN-KLINIKUM's Revenue has seen impressive growth In the last two years, rising from 1.56€B to 1.65€B – a growth of 6.23%. For the following year, the 0 analysts predict that RHÖN-KLINIKUM's Revenue will drop by 3.24%, reaching 1.60€B. In 2030, the professionals' prediction is that RHK's Revenue will decrease by 3.20%, reaching 1.60€B.

2023 Rev Forecast
1.60€B
2024 Rev Forecast
1.59€B
2025 Rev Forecast
1.59€B
2026 Rev Forecast
1.61€B
2027 Rev Forecast
1.61€B
2028 Rev Forecast
1.60€B
2029 Rev Forecast
1.60€B
2030 Rev Forecast
1.60€B

RHÖN-KLINIKUM Dividend per Share Forecast for 2023 - 2025 - 2030

RHÖN-KLINIKUM Free Cash Flow Forecast for 2023 - 2025 - 2030

RHÖN-KLINIKUM EBITDA Forecast for 2023 - 2025 - 2030

In the last two years, RHÖN-KLINIKUM's EBITDA has seen an increase, rising from 84.45€M to 97.61€M. This represents a growth of 15.58%. According to the 0 analysts polled, in the next year, RHÖN-KLINIKUM's EBITDA will fall by 5.55%, reaching 92.19€M. By 2030, professionals believe that RHÖN-KLINIKUM's EBITDA will have decreased by 5.36%, falling to 92.38€M.

2023 EBITDA Forecast
0.09€B
2024 EBITDA Forecast
0.09€B
2025 EBITDA Forecast
0.09€B
2026 EBITDA Forecast
0.09€B
2027 EBITDA Forecast
0.09€B
2028 EBITDA Forecast
0.09€B
2029 EBITDA Forecast
0.09€B
2030 EBITDA Forecast
0.09€B

RHÖN-KLINIKUM EBIT Forecast for 2023 - 2025 - 2030

RHÖN-KLINIKUM's EBIT has seen growth In the last two years, going from 18.05€M to 31.31€M – a gain of 73.46% For the next year, 0 analysts project RHÖN-KLINIKUM's EBIT to drop by 19.27%, reaching 25.28€M. By 2030, professionals believe that RHÖN-KLINIKUM's EBIT will decrease by 17.21%, reaching 25.92€M – a concerning trend for the company.

2023 EBIT Forecast
0.03€B
2024 EBIT Forecast
0.02€B
2025 EBIT Forecast
0.02€B
2026 EBIT Forecast
0.03€B
2027 EBIT Forecast
0.03€B
2028 EBIT Forecast
0.03€B
2029 EBIT Forecast
0.03€B
2030 EBIT Forecast
0.03€B

RHÖN-KLINIKUM EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last two years, RHÖN-KLINIKUM's EPS has decreased from 0.57€ to 0.00€ – a 100.00% drop. In the next year, analysts believe that EPS will reach 0.00€ – an increase of 100.00%. For the next six years, the forecast is for EPS to grow by 100.00%.

2025 EPS Forecast
0.00€
2026 EPS Forecast
0.00€
2027 EPS Forecast
0.00€
2028 EPS Forecast
0.00€
2029 EPS Forecast
0.00€
2030 EPS Forecast
0.00€